88IV - PR Newswire Asia's news


Nuevocor Appoints Dr. Monica Shah as Chief Medical Officer SINGAPORE, PARIS and PHILADELPHIA , April 28, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company developing novel therapies for patients suffering from life-threatening cardiomyopathies, ... 2026-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical CHONGQING, China , April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin ... 2026-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HoneyNaps Expands into Boston's Kendall Square, Accelerating Global Partnerships in AI Sleep Healthcare New office in Boston-Cambridge innovation hub to expand partnerships with healthcare and life sciences leaders Supported through a Korea Health Industry Development Institute global expansion program ... 2026-04-28T Biotechnology Computer Software Computer/Electronics Health Care/Hospital
Ivonescimab Receives Major Recommendations Across Multiple Therapies in the 2026 CSCO NSCLC Guideline HONG KONG , April 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that ivonescimab, the company's first-in-class PD-1/VEGF bispecific antibody, ... 2026-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California SINGAPORE , April 28, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership ... 2026-04-28T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan TOKYO , April 28, 2026 /PRNewswire/ -- Cordis, a global leader in interventional cardiovascular technologies, today announces the launch and availability of the SELUTION SLR™ PTA Drug-Eluting Balloon ... 2026-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia. ... 2026-04-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026 LONDON , April 27, 2026 /PRNewswire/ -- Concept Medical Inc. , today announced the presentation of preliminary 3-year follow-up data from the SIRONA randomised trial at the Charing Cross (CX) Symposium ... 2026-04-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026 Total Revenue Reached RMB 12.44 Billion; Revenue from Continuing Operations Up 39.4% YoY Adjusted Non-IFRS Net Profit Up 71.7% YoY to RMB 4.60 Billion Backlog for Continuing Operations Up 23.6% ... 2026-04-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026 - Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 ... 2026-04-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology